Machine learning, predictive models, and computational biology—how AI is changing discovery workflows and probability of success.
Integrating AI-powered systems and forging powerful collaborations are redefining efficiencies in healthcare payer operations and expanding biopharma drug development pipelines with promising potential therapies.
Integrating AI-powered systems and forging powerful collaborations are redefining efficiencies in healthcare payer operations and expanding biopharma drug development pipelines with promising potential therapies.
READ MORE
Elevance Health employs artificial intelligence to enhance operational efficiencies in approvals, claims processing, and member support, while maintaining human oversight on denial decisions.
The Mayo Clinic has entered a health data partnership with Merck to aid in the training of AI systems aimed at enhancing prognosis accuracy, marking an important step in AI application in healthcare.
Anterior recently raised $40 million to expand its innovative AI platform that automates administrative clinical approvals for health plans, aiming to drastically reduce delays and costs.
Leading pharmaceutical companies are intensifying their adoption of AI technologies, which are currently influencing their business performance through avenues beyond traditional drug discovery.
Epic Systems has introduced a long-anticipated AI Charting feature that stands to significantly disrupt the ambient scribe market. This innovative technology integrates artificial intelligence to transform clinical documentation processes.
Alaffia Health announced a $55 million Series B funding round for its clinically grounded AI platform aimed at reducing waste and risk in healthcare insurance claims, marking a significant step forward for payer-side AI adoption.
Bessemer Venture Partners forecasts 2026 as a pivotal year for healthcare AI, driven by clinical AI adoption, AI-first value-based care firms, and digital health infrastructure advancements.
Amissa, a startup supported by the NIH, has launched an AI-powered platform designed to enhance the tracking and treatment of menopause and perimenopause by integrating data from multiple sources.
Nvidia’s new collaborations with Eli Lilly and Thermo Fisher mark an intensified push to integrate artificial intelligence into the foundation of pharmaceutical research and drug discovery infrastructure.
Emerging AI platforms by Anthropic and OpenAI are shaping healthcare with innovative tools targeting patients, providers, and researchers. This article compares their approaches and potential impacts.
